Angiotensin II-induced vasodilation via type 2 receptor: Role of bradykinin and nitric oxide

International Immunopharmacology

Volumn 8, Issue 2, 2008, Pages 312-318

  Yayama, Katsutoshi ^a   Okamoto, Hiroshi ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Bradykinin; Endothelial nitric oxide synthase; Nitric oxide; Receptors

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; BRADYKININ; CAVEOLIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; DYNAMIN II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; ICATIBANT; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHLORIDE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; CAPACITANCE BLOOD VESSEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR UPREGULATION; REVIEW; SHEAR STRESS; VASODILATATION;

ANGIOTENSIN II; ANIMALS; BRADYKININ; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RATS; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION; UP-REGULATION; VASOCONSTRICTION; VASODILATION;

EID: 37549028011     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.06.012     Document Type: Review

References (45)

1. Morishita R., Higaki J., Miyazaki M., and Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension 19 suppl II (1992) II62-II67
2. Itoh H., Muloyama M., Pratt R.E., Gibbons G.H., and Dzau V.J. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 91 (1993) 2268-2272
3. Wolf G., Zihadeh F.N., Zahner G., and Stahl R.A.K. Angiotensin II is mitogenic for cultured rat glomerular endothelial cells. Hypertension 27 (1996) 897-905
4. Scott-Burden T., Resink T.J., Hahn A.W., and Buhler F.R. Angiotensin-induced growth related metabolism is activated in cultured smooth muscle cells from spontaneously hypertensive rats and Wistar-Kyoto rats. Am J Hypertens 4 (1991) 183-188
5. Chiu A.T., Herblin W.F., McCall D.E., Ardecky R.J., Carini D.J., Dunica J.V., et al. Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 165 (1989) 196-203
6. Timmermans P.B., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 25 (1993) 205-251
7. Inagami T. Recent progress in molecular and cell biological studies of angiotensin receptors. Curr Opin Nephrol Hypertens 4 (1995) 47-54
8. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83 (1998) 1182-1191
9. Viswanathan M., Tsutsumi K., Correa F.M.A., and Saavedra J.M. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 179 (1991) 1361-1367
10. Batenburg W.W., Garrelds I.M., Bernasconi C.C., Juillerat L., van Kats J.P., Saxena P.R., et al. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 109 (2004) 2296-2301
11. Scheuer D.A., and Perrone M.H. Angiotensin type 2 receptors mediate depressor phase of biphasic pressure response to angiotensin. Am J Physiol 264 (1993) R917-R923
12. 1 receptor antagonism in conscious normotensive but not hypertensive rats. Am J Physiol Heart Circ Physiol 288 (2005) H2289-H2297
13. Hein L., Barsh G.S., Pratt R.E., Dzau V.J., and Kobilka B.K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature [Lond] 377 (1995) 744-747
14. Ichiki T., Labosky P.A., Shiota C., Okuyama S., Imagawa Y., Fogo A., et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature [Lond] 377 (1995) 748-750
15. Akishita M., Yamada H., Dzau V.J., and Horiuchi M. Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor. Biochem Biophys Res Commun 261 (1999) 345-349
16. Tsutsumi Y., Matsubara H., Masaki H., Kurihara H., Murasawa S., Takai S., et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 104 (1999) 925-935
17. Otsuka S., Sugano M., Makino N., Sawada S., Hata T., and Niho Y. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 32 (1998) 467-472
18. Hutchinson H.G., Hein L., Fujinaga M., and Pratt R.E. Modulation of vascular development and injury by angiotensin II. Cardiovasc Res 41 (1999) 689-700
19. 2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. Hypertension 33 (1999) 366-372
20. Doggrell S.A., and Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 39 (1998) 89-105
21. Yayama K., Horii M., Hiyoshi H., Takano M., Okamoto H., Kagota S., et al. Up-regulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload. J Pharmacol Exp Ther 308 (2004) 736-743
22. 2 receptors in the pressure-overloaded aorta after banding. Hypertension 43 (2004) 1258-1263
23. Baker K.M., Chernin M.I., Wixson S.K., and Aceto J.F. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 259 (1990) H324-H349
24. Hiyoshi H., Yayama K., Takano M., and Okamoto H. Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension 45 (2005) 967-973
25. Bonnet F., Cooper M.E., Carey R.M., Casley D., and Cao Z. Vascular expression of angiotensin type 2 receptor in the adult rat: influence of angiotensin II infusion. J Hypertens 19 (2001) 1075-1081
26. 1 receptor blockade. Hypertension 40 (2002) 516-520
27. You D., Loufrani L., Baron C., Levy B.I., Widdop R.E., and Henrion D. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 111 (2005) 1006-1011
28. Savoia C., Touyz R.M., Volpe M., and Schiffrin E.L. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 49 (2007) 341-346
29. 1 receptor-mediated contraction in the rat uterine artery: involvement of bradykinin and nitric oxide. Br J Pharmacol 140 (2003) 987-996
30. 2 receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol 136 (2002) 484-491
31. Carey M., Wang Z.-Q., and Siragy H.M. Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension 35 (2000) 155-163
32. 2 receptor. Trends Endocrinol Metab 11 (2000) 1-6
33. Fulton D., Gratton J.-P., and Sessa W.C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. J Pharmacol Exp Ther 299 (2001) 818-824
34. Yayama K., Hiyoshi H., Imazu D., and Okamoto H. Angiotensin II stimulates endothelial NO synthase phosphorylation in thoracic aorta of mice with abdominal aortic banding via type 2 receptor. Hypertension 48 (2006) 958-964
35. Seyedi N., Xu X.B., Najiletti A., and Hintze T.H. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension 26 (1995) 164-170
36. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 31 (1998) 349-355
37. 2 receptor in a renal wrap hypertension model. Hypertension 33 (1999) 1237-1242
38. 2 receptors. Circ Res 94 (2004) 1623-1629
39. 2 subtype receptor of angiotensin. Hypertension 38 (2001) 1150-1169
40. Watanabe T., Barker T.A., and Berk B.C. Angiotensin II and the endothelium. Diverse signals and effect. Hypertension 45 (2005) 1-7
41. Dedio J., Wiemer G., Rutten H., Dendorfer A., Scholkens B.A., Muller-Esterl W., et al. Tissue kallikrein KLK is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins. Biol Chem 382 (2001) 1483-1490
42. Yayama K., Kunimatsu N., Teranishi Y., Takano M., and Okamoto H. Tissue kallikrein is synthesized and secreted by human vascular endothelial cells. Biochim Biophys Acta 1593 (2003) 231-238
43. 2 receptor functional heterodimerization. Hypertension 48 (2006) 316-322
44. de Gasparo M., Catt K.J., Inagami T., Wright W., and Unger TH. International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52 (2000) 415-472
45. Leeb-Lundberg L.M.F., Marceau F., Muller-Esterl W., Pettibone D.J., and Zurau B.L. International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57 (2005) 27-77